Oragenics
OGEN
#9875
Rank
HK$33.69 M
Marketcap
HK$2.99
Share price
20.35%
Change (1 day)
-89.78%
Change (1 year)

P/E ratio for Oragenics (OGEN)

P/E ratio as of November 2024 (TTM): -0.0600

According to Oragenics's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.0600343. At the end of 2022 the company had a P/E ratio of -0.9362.

P/E ratio history for Oragenics from 2004 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-0.9362-71.95%
2021-3.34256%
2020-0.9375-33.29%
2019-1.41103.23%
2018-0.6915-58.81%
2017-1.68-51.19%
2016-3.44-26.62%
2015-4.69-15.73%
2014-5.5612.83%
2013-4.9377.89%
2012-2.77269.05%
2011-0.7509-64.36%
2010-2.11-29.42%
2009-2.99102.99%
2008-1.47-64.13%
2007-4.10-40.36%
2006-6.88251.74%
2005-1.95-111.17%
200417.5

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-5.63 9,284.14%๐Ÿ‡บ๐Ÿ‡ธ USA
52.2-87,046.13%๐Ÿ‡บ๐Ÿ‡ธ USA
13.0-21,777.11%๐Ÿ‡บ๐Ÿ‡ธ USA
20.2-33,721.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.0271-54.83%๐Ÿ‡บ๐Ÿ‡ธ USA
11.1-18,553.12%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.